Buy 1B-LSD In Blotters Online USA

1B-LSD (also known as N1-butyryl or BOL-148) is an acylated derivative of lysergic acid diethylamide (LSD). 1B-LSD has been sold as a designer drug and psychoactive research chemical, first appearing on the online research chemical market in 2017.

BOL-148 or N1-butyryl, is an acylated derivative of lysergic acid diethylamide or LSD that was first synthesized in 2017. The compound has been sold online since early 2017 as a designer drug and psychoactive “recreational chemical.”

1B-LSD (1-butyryl-lysergic acid diethylamide) is a psychedelic substance of the lysergamide class. It is a homolog of LSD, in which the diethylamide functional group has been replaced with a butyryl group. It is thought to be roughly one-seventh as potent as LSD, with an efficacy of around 30% at LSD’s active dose.

1B-LSD is an acylated derivative of lysergic acid diethylamide (LSD). 1B-LSD has been used to study the serotonin system.

1B-LSD is a controlled substance in New Zealand.

1B-LSD is an analog of lysergic acid diethylamide (LSD), a psychedelic drug known for its ability to alter one’s state of consciousness. Test performed on mice showed that 1B-LSD was active at around 1/7 the potency of LSD itself, putting it roughly in the same range as 2C-E.

1B-LSD is a psychedelic drug analog of lysergic acid diethylamide (LSD). 1B-LSD is a lysergamide, specifically a derivative of lysergic acid. Its systematic name is N-benzoyl-N-(1-butanol)-lysergic acid diethylamide. Alexander Shulgin first synthesized the drug and reported in his book TiHKAL (Tryptamines I Have Known And Loved) under the code name “BOL-148”.

1B-LSD is a psychedelic drug analog of lysergic acid diethylamide (LSD). It is a lysergamide, specifically a derivative of lysergic acid. Its systematic name is N-benzoyl-N-(1-butanol)-lysergic acid diethylamide.

1B-LSD is a psychedelic drug analog of lysergic acid diethylamide (LSD).

There have been no formal clinical studies by mainstream scientists and researchers of N1-Butyl-Lysergic Acid Diethylamide (also known as 1B-LSD or 1B-LAD) before its classification as a Schedule I Drug. We have created a web page and published information about this new psychoactive substance.

It is illegal to possess 1B-LSD, so we created this page because there is so little information available online. We want to share the facts about this new, unregulated substance with users and non-users alike.

The novel lysergamide derivative  is a new psychedelic substance of the lysergamide family. It is being sold as a designer drug under various names and marketed as an alternative to LSD and LSA.

LSD (Lysergic acid diethylamide) is a psychedelic drug known for its ability to alter the senses and cause hallucinations. It causes unconsciousness in high doses.

1B-lysergic acid diethylamide is an acylated derivative of LSD. It appears as a white, odorless powder. 1B-LSD is not scheduled at the federal level in the United States but may be considered an analog (of LSD) and is therefore illegal to sell for human consumption or possess in the United States under Schedule I(c) of the Controlled Substances Act.

Our 1B-LSD is a non-psychoactive substance, classified as a tryptamine. It is considered an N-acyl derivative of lysergic acid diethylamide (LSD). We provide this product for research purposes only and strongly advise against human consumption.

It is an analog of lysergic acid diethylamide. It is closely related to LSD and has similar effects but with a slightly more psychedelic headspace. This compound has been linked to local deaths resulting from an overdose.

The N-butyryl group makes the compound an analog of LSD and, therefore -like it- a class A drug.

Everest Chemicals makes it possible for you to access the best quality research chemicals , Psychedelics, Cannabinoids and more. We ship allover USA, UK, Europe, Australia, Canada and Asia